SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-012204
Filing Date
2019-07-08
Accepted
2019-07-08 16:04:22
Documents
2
Period of Report
2019-07-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k070519_adialpharmaceut.htm 8-K 36791
2 MASTER SERVICES AGREEMENT AND RELATED STATEMENT OF WORK, DATED JULY 5, 2019 f8k070519ex10-1_adialpharmac.htm EX-10.1 77251
  Complete submission text file 0001213900-19-012204.txt   115403
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 19945388
SIC: 2834 Pharmaceutical Preparations